1
ROSS Ruth Alexandra, PAROLARO Daniela: [fr] PHYTOCANNABINOÏDES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER, [en] PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF CANCER. ROSS Ruth Alexandra, PAROLARO Daniela, GW PHARMA, OTSUKA PHARMACEUTICAL CO, HARRISON GODDARD FOOTE, March 21, 2013: WO/2013/038157 (2 worldwide citation)

[en] The present invention relates to the use of phytocannabinoids in the treatment of cancer. More particularly it relates to the use of phytocannabinoids in the treatment of tumour cell invasion and cell migration or metastases. Cancers, where invasion and cell migration plays a key role in progno ...


2
PAROLARO DANIELA: Phytocannabinoids in the treatment of cancer. Gw Pharma, Harrison Goddard Foote, September 15, 2011: WO/2011/110866 (1 worldwide citation)

This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.


3
Daniela Parolaro, Paola Massi, Angelo Antonio Izzo, Francesca Borelli, Gabriella Aviello, Vincenzo Di Marzo, Luciano De Petrocellis, Aniello Schiano Moriello, Alessia Ligresti, Ruth Alexandra Ross, Lesley Ann Ford, Sharon Anavi Goffer, Manuel Guzman, Guillermo Velasco, Mar Lorente, Sofia Torres, Tetsuro Kikuchi, Geoffrey Guy, Colin Stott, Stephen Wright, Alan Sutton, David Potter, Etienne De Meijer: Phytocannabinoids in the treatment of cancer. GW Pharma, Otsuka Pharmaceutical Co, Wolf Greenfield & Sacks P C, July 29, 2014: US08790719

This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.


4

5

6
PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER. OTSUKA PHARMACEUTICAL CO, GW PHARMA, March 7, 2013: US20130059018-A1

This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.


7
Parolaro Daniela, Massi Paola, Izzo Angelo Antonio, Borelli Francesca, Aviello Gabriella, Di Marzo Vincenzo, De Petrocellis Luciano, Moriello Aniello Schiano, Ligresti Alessia, Ross Ruth Alexandra, Ford Lesley Ann, Anavi goffer Sharon, Guzman Manuel, Velasco Guillermo, Lorente Mar, Torres Sofia, Kikuchi Tetsuro, Guy Geoffrey, Stott Colin, Wright Stephen, Sutton Alan, Potter David, De Meijer Etienne: Phytocannabinoids in the treatment of cancer. GW Pharma, otsuka Pharma, kong jing quan lujun, January 9, 2013: CN201180023652

This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.


8
PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF CANCER. Otsuka Pharmaceutical, GW Pharma, August 7, 2014: US20140221469-A1

The present invention relates to the use of phytocannabinoids in the treatment of cancer. More particularly it relates to the use of phytocannabinoids in the treatment of tumour cell invasion and cell migration or metastases. Cancers, where invasion and cell migration plays a key role in prognosis i ...


9
PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER. GW Pharma, Otsuka Pharmaceutical Co, March 26, 2015: US20150086653-A1

This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.